Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
2.
3.

Analysis of multivariate recurrent event data with time-dependent covariates and informative censoring.

Zhao X, Liu L, Liu Y, Xu W.

Biom J. 2012 Sep;54(5):585-99. doi: 10.1002/bimj.201100194.

PMID:
22886587
4.

Semiparametric analysis for recurrent event data with time-dependent covariates and informative censoring.

Huang CY, Qin J, Wang MC.

Biometrics. 2010 Mar;66(1):39-49. doi: 10.1111/j.1541-0420.2009.01266.x.

5.

Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.

Gattermann N, Hofmann WK, Meessen A, Schmitz S, Tsamaloukas A, Vollmer T, Wedding U, Plesnila-Frank C, Schramm W, Berger K.

Onkologie. 2008 Sep;31(8-9):477-84. doi: 10.1159/000142900. Review.

PMID:
18787357
6.

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.

Nolte F, Höchsmann B, Giagounidis A, Lübbert M, Platzbecker U, Haase D, Lück A, Gattermann N, Taupitz M, Baier M, Leismann O, Junkes A, Schumann C, Hofmann WK, Schrezenmeier H.

Ann Hematol. 2013 Jan;92(2):191-8. doi: 10.1007/s00277-012-1594-z.

PMID:
23073603
7.

Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study.

Ning J, Rahbar MH, Choi S, Piao J, Hong C, Del Junco DJ, Rahbar E, Fox EE, Holcomb JB, Wang MC.

Stat Methods Med Res. 2015 Jul 9. pii: 0962280215593974. [Epub ahead of print]

8.
9.

Analyzing semi-competing risks data with missing cause of informative terminal event.

Zhou R, Zhu H, Bondy M, Ning J.

Stat Med. 2017 Feb 28;36(5):738-753. doi: 10.1002/sim.7161.

PMID:
27813148
10.

Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome.

Potter VT, Krishnamurthy P, Barber LD, Lim Z, Kenyon M, Ireland RM, de Lavallade H, Dhouri A, Marsh JC, Marcus R, Devereux S, Ho A, Pagliuca A, Mufti GJ.

Biol Blood Marrow Transplant. 2014 Jan;20(1):111-7. doi: 10.1016/j.bbmt.2013.10.021.

11.

Multivariate frailty models for two types of recurrent events with a dependent terminal event: application to breast cancer data.

Mazroui Y, Mathoulin-Pélissier S, Macgrogan G, Brouste V, Rondeau V.

Biom J. 2013 Nov;55(6):866-84. doi: 10.1002/bimj.201200196.

PMID:
23929494
12.

Semiparametric Regression Estimation for Recurrent Event Data with Errors in Covariates under Informative Censoring.

Yu H, Cheng YJ, Wang CY.

Int J Biostat. 2016 Nov 1;12(2). pii: /j/ijb.2016.12.issue-2/ijb-2016-0001/ijb-2016-0001.xml. doi: 10.1515/ijb-2016-0001.

PMID:
27497870
13.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429.

14.

Analyzing Recurrent Event Data With Informative Censoring.

Wang MC, Qin J, Chiang CT.

J Am Stat Assoc. 2001;96(455). doi: 10.1198/016214501753209031.

15.

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.

Delforge M, Selleslag D, Triffet A, Mineur P, Bries G, Graux C, Trullemans F, MacDonald K, Abraham I, Pluymers W, Ravoet C.

Ann Hematol. 2011 Jun;90(6):655-66. doi: 10.1007/s00277-011-1164-9.

PMID:
21318574
16.

Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications.

Gupta P, LeRoy SC, Luikart SD, Bateman A, Morrison VA.

Leuk Res. 1999 Oct;23(10):953-9.

PMID:
10573142
17.

Pathogen-reduced platelets for the prevention of bleeding.

Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009072. doi: 10.1002/14651858.CD009072.pub2. Review.

PMID:
23543569
18.

Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008.

McQuilten ZK, Polizzotto MN, Wood EM, Sundararajan V.

Transfusion. 2013 Aug;53(8):1714-21. doi: 10.1111/trf.12054.

PMID:
23305556
19.

Joint Models of Longitudinal Data and Recurrent Events with Informative Terminal Event.

Kim S, Zeng D, Chambless L, Li Y.

Stat Biosci. 2012 Nov 1;4(2):262-281.

20.
Items per page

Supplemental Content

Support Center